CC-4047
Term · Oncology and biomedicine · MLC-T-ONC-001512
A drug that is similar to thalidomide and is used alone or with other drugs to treat adults with certain types of multiple myeloma or Kaposi sarcoma. It is also being studied in the treatment of other types of cancer. CC-4047 may help the immune system kill cancer cells. It may also prevent the growth of new blood vessels that tumors need to grow. CC-4047 is a type of immunomodulating agent and a type of antiangiogenesis agent. Also called pomalidomide and Pomalyst.
| Identifier | MLC-T-ONC-001512 |
|---|---|
| Field | Oncology and biomedicine |
| Expansions | pomalidomide; Pomalyst |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-001512",
"term": "CC-4047",
"field": "Oncology and biomedicine",
"definition": "A drug that is similar to thalidomide and is used alone or with other drugs to treat adults with certain types of multiple myeloma or Kaposi sarcoma. It is also being studied in the treatment of other types of cancer. CC-4047 may help the immune system kill cancer cells. It may also prevent the growth of new blood vessels that tumors need to grow. CC-4047 is a type of immunomodulating agent and a type of antiangiogenesis agent. Also called pomalidomide and Pomalyst.",
"expansions": [
"pomalidomide",
"Pomalyst"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/cc-4047/"
}
Record 4,353 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.